Skip to main content
MESOBLAST LTD logo

MESOBLAST LTD — Investor Relations & Filings

Ticker · MESO ISIN · US5907171046 ASX Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2024-03-21 Regulatory Filings
Country US United States of America
Listing ASX MESO

About MESOBLAST LTD

https://www.mesoblast.com/

Mesoblast is a regenerative medicine company that develops allogeneic (off-the-shelf) cellular medicines for severe and life-threatening inflammatory conditions. The company utilizes its proprietary mesenchymal lineage cell (MSC) technology platform to create treatments for inflammatory ailments, cardiovascular disease, and chronic back pain. The technology sources rare MSCs from the bone marrow of healthy adult donors, which are then expanded using proprietary processes for industrial-scale manufacturing. A key feature of these cells is their ability to be administered without donor-recipient matching or immune suppression. The therapeutic candidates are designed to respond to tissue damage by secreting mediators that promote tissue repair and modulate immune responses. The company's late-stage portfolio includes remestemcel-L for acute graft versus host disease (GVHD) and acute respiratory distress syndrome (ARDS), REVASCOR® for advanced chronic heart failure, and MPC-06-ID for chronic low back pain.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2024-03-21 English
AMENDMENT NO. 2 TO SCHEDULE 13G
Major Shareholding Notification
2024-03-21 English
Proposed issue of securities - MSB 5 pages 17.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed placement of 3,100,000 ordinary fully paid shares by Mesoblast Limited. It includes specifics such as the issue price, proposed issue date, and compliance with ASX Listing Rules. The content is focused on announcing a new share issue and capital raising activity. There are no financial statements or management discussion of results, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or voting result announcement. The document fits the definition of a Capital/Financing Update as it provides detailed information about a fundraising activity and capital structure change.
2024-03-19 English
Change in substantial holding 4 pages 1.4MB
Regulatory Filings
2024-03-19 English
Cleansing Notice 1 page 230.2KB
Capital/Financing Update Classification · 95% confidence The document is a notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of fully paid ordinary shares by Mesoblast Limited. It details compliance with disclosure requirements and confirms no excluded information exists. The content focuses on a capital raising event and legal compliance related to share issuance, not a full financial report or earnings release. The document length is short (1510 characters) and is a formal regulatory notice about a capital transaction. This fits the definition of a Capital/Financing Update (CAP).
2024-03-18 English
Appendix 2A 20 pages 489.6KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The document is a regulatory form used to apply for listing new securities, not a financial report or earnings release. It is not an announcement of voting results, management changes, or legal proceedings. It is a specific regulatory filing related to capital markets and securities quotation. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into other specific categories like Capital/Financing Update or Share Issue/Capital Change, since it is an application form rather than an announcement of issuance or capital change itself.
2024-03-17 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.